Skip to main content
. 2017 Jan 24;39(1):340–349. doi: 10.1080/0886022X.2017.1279553

Figure 4.

Figure 4.

Relative expression levels of (A) CD11c messenger RNA (mRNA), (B) inducible nitric oxide synthase (iNOS) mRNA, and (C) CD206 mRNA in the kidneys in the sham-operated (sham, n = 10), vehicle-treated (veh, n =8), and alogliptin-treated (alogliptin, n = 9) groups. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA was used as the internal control to adjust for unequal total mRNA content. A, B *p <0.01 compared with the sham-operated group. C $p < 0.05 compared with the sham-operated group. (D) Ratio of CD206 mRNA to CD68 mRNA in each group. $p < 0.05 compared with the sham-operated group.